Glenmark Pharmaceuticals Share Price Today: Should You Buy or Not?

Glenmark Pharmaceuticals share price today is Rs 2370.0, having gained 0.79 percent from its previous close of Rs 2351.4 in today’s session on NSE. The Pharmaceuticals company trades under the symbol GLENMARK with a market capitalisation of Rs 42,000 Cr. With a day high of Rs 2373.3 and a low of Rs 2322.0, investor interest in Glenmark Pharmaceuticals is positive heading into the close. The central question for investors is whether Glenmark Pharmaceuticals share price today offers a buying opportunity worth acting on.

Click Here – Get Free Investment Predictions on Univest

Glenmark Pharmaceuticals Company Overview

Mumbai-based pharma company with a strong branded generics business in India and US generics with a dermatology and respiratory focus.

Parameter	Details (May 27, 2026)
NSE Symbol	GLENMARK
Sector	Pharmaceuticals
CMP (Live)	Rs 2370.0
Today’s High	Rs 2373.3
Today’s Low	Rs 2322.0
Previous Close	Rs 2351.4
Market Cap	Rs 42,000 Cr

Glenmark Pharmaceuticals Share Price Today: Key Levels and Recent Performance

Glenmark Pharmaceuticals share price today at Rs 2370.0 has gained 0.79 percent from yesterday’s close of Rs 2351.4. Intraday trading saw a range of Rs 2322.0 to Rs 2373.3, indicating active buying interest with volume-backed momentum. The day range gives investors reference points for entry and exit decisions on the stock.

At the current market cap of Rs 42,000 Cr, Glenmark Pharmaceuticals is an established player in the Pharmaceuticals space. Investors tracking Glenmark Pharmaceuticals share price today should watch the intraday high of Rs 2373.3 as immediate resistance and today’s low of Rs 2322.0 as near-term support before making investment decisions.

Glenmark Pharmaceuticals Financial Performance and Business Update

Glenmark Pharmaceuticals Revenue and Earnings Trajectory

Glenmark Pharmaceuticals has been building its revenue base through its core Pharmaceuticals business. The company’s earnings profile is shaped by demand trends in its primary markets, pricing dynamics and operating leverage as volumes scale. Investors tracking Glenmark Pharmaceuticals share price today should review the latest quarterly results for revenue growth, EBITDA margin trends and PAT performance to assess earnings momentum.

Balance Sheet and Cash Flow Indicators

Balance sheet quality including debt levels, working capital efficiency and free cash flow generation are key metrics for evaluating Glenmark Pharmaceuticals as a long-term investment. Companies in the Pharmaceuticals sector with improving return on equity and manageable debt-to-equity ratios tend to sustain long-term price appreciation and deserve premium valuations.

Management Guidance and Sector Positioning

Management commentary on order book, revenue guidance and capacity plans provides the clearest forward indicator for Glenmark Pharmaceuticals share price today’s fundamental trajectory. Sector tailwinds from India’s economic growth, infrastructure investment and policy support for the Pharmaceuticals sector provide a favourable macro backdrop for the company’s medium-term performance.

Reasons to Consider Buying Glenmark Pharmaceuticals Share Today

US Generic Market Opportunity

The US is the world’s largest generic pharmaceutical market. Indian pharma companies with FDA-approved facilities and complex generic pipelines are well positioned.

Domestic Branded Generic Growth

India’s domestic formulations market is growing at 8 to 12 percent annually, driven by increasing healthcare penetration and affordability.

Biosimilars Pipeline Potential

Companies investing in biosimilars have significant upside potential as several blockbuster biologics lose patent protection.

API Self-Reliance Drive

India’s focus on reducing API import dependence from China creates structural demand for domestic API manufacturers.

Key Risks Before Buying Glenmark Pharmaceuticals Share Today

US FDA Regulatory Risk

Adverse observations or warning letters from the US FDA can severely impact revenues from the key US market.

US Generic Price Erosion

The US generics market is highly competitive with accelerating price erosion. Revenue from specific molecules can decline sharply.

API Input Cost Volatility

Pharma companies relying on imported APIs from China face supply disruption and cost volatility risks.

Technical View on Glenmark Pharmaceuticals Share Price Today

Glenmark Pharmaceuticals share price today at Rs 2370.0 is trading above its previous close, suggesting near-term buying momentum. The intraday high of Rs 2373.3 serves as immediate resistance for bulls, while the day low of Rs 2322.0 provides the first technical support level to watch. A sustained close above today’s high could trigger further upside momentum.

Investors should track key moving averages including the 20-day, 50-day and 200-day SMA relative to Glenmark Pharmaceuticals share price today to assess the broader trend direction. RSI and volume indicators alongside price action will help determine whether the current move has conviction.

Check Glenmark Pharmaceuticals live price and fundamentals on the Univest Screener

Should You Buy Glenmark Pharmaceuticals Share Today?

Glenmark Pharmaceuticals share price today at Rs 2370.0 presents a case that requires balancing sector growth potential against stock-specific valuation and risk factors. The Pharmaceuticals sector is showing positive momentum and Glenmark Pharmaceuticals is positioned within it with improving momentum and institutional interest. Long-term investors with a 2 to 3 year horizon may find merit in the stock on meaningful dips, while short-term traders should define clear entry and exit levels based on technical analysis.

Any investment decision on Glenmark Pharmaceuticals share price today should be preceded by a thorough review of the latest financials, sector outlook and portfolio fit. Investors are strongly advised to consult a SEBI-registered financial advisor before making any investment decision.

Download the Univest iOS App or Univest Android App to track Glenmark Pharmaceuticals share price today and get daily stock research.

Conclusion

Glenmark Pharmaceuticals share price today at Rs 2370.0 reflects a company with a meaningful presence in India’s Pharmaceuticals sector. The structural growth drivers for the sector, combined with Glenmark Pharmaceuticals’s competitive positioning, make it a name worth tracking for long-term investors. However, valuation discipline and awareness of sector-specific risks are essential before committing capital at current levels. Monitor quarterly earnings, management commentary and sector-level developments to make informed decisions about Glenmark Pharmaceuticals share price today.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions on Glenmark Pharmaceuticals Share Price Today

What is Glenmark Pharmaceuticals share price today?

Ans. Glenmark Pharmaceuticals share price today is Rs 2370.0 as of May 27, 2026, with an intraday high of Rs 2373.3 and a low of Rs 2322.0. The stock has gained 0.79 percent from its previous close of Rs 2351.4. It trades on NSE under the symbol GLENMARK in the Pharmaceuticals sector.

Should I buy Glenmark Pharmaceuticals share today?

Ans. Glenmark Pharmaceuticals share price today at Rs 2370.0 requires careful analysis before investing. Consider the company’s Pharmaceuticals sector positioning, earnings trajectory and valuation relative to peers. Long-term investors may consider accumulating on dips while short-term traders should use defined stop-losses. Always consult a SEBI-registered financial advisor before investing.

What is the sector of Glenmark Pharmaceuticals?

Ans. Glenmark Pharmaceuticals belongs to the Pharmaceuticals sector and trades on NSE under symbol GLENMARK with a market capitalisation of Rs 42,000 Cr. Mumbai-based pharma company with a strong branded generics business in India and US generics with a

What is Glenmark Pharmaceuticals share price target?

Ans. Share price targets for Glenmark Pharmaceuticals depend on earnings growth, sector tailwinds and valuation re-rating potential in the Pharmaceuticals space. Investors should track quarterly earnings and sector-level developments to assess price target milestones. Use the Univest Screener for updated analyst targets and research on Glenmark Pharmaceuticals share price today.

What is the market cap of Glenmark Pharmaceuticals today?

Ans. The market capitalisation of Glenmark Pharmaceuticals is approximately Rs 42,000 Cr as of May 27, 2026. The company trades on NSE under symbol GLENMARK in the Pharmaceuticals sector.

What are the key risks in Glenmark Pharmaceuticals share?

Ans. Key risks for Glenmark Pharmaceuticals include us fda regulatory risk, us generic price erosion, and api input cost volatility. Investors should carefully evaluate these risk factors alongside the growth potential before investing in Glenmark Pharmaceuticals share price today.

How to buy Glenmark Pharmaceuticals shares?

Ans. You can buy Glenmark Pharmaceuticals shares by opening a demat and trading account with a SEBI-registered broker. Search for NSE symbol GLENMARK, check Glenmark Pharmaceuticals share price today, and place a buy order at market or limit price. The Univest app provides a convenient platform to track Glenmark Pharmaceuticals live price.

Where can I track Glenmark Pharmaceuticals share price live?

Ans. You can track Glenmark Pharmaceuticals share price today live on NSE under ticker GLENMARK. The Univest Screener provides real-time data, fundamentals, FII and DII flows, and research for Glenmark Pharmaceuticals. The Univest app also delivers daily stock recommendations and Pharmaceuticals sector analysis.